Nurse Practitioner, Family · Fort Wayne, IN
NPI
1326534132
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1721 Magnavox Way Ste B
Fort Wayne, IN, 46804
Phone (260) 748-3650
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
3,724 services
Medicare patients, 2024
297
Average age 64
Drug cost, 2024
$1.1M
9,530 prescriptions
Company payments, 2025
$803
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kara R Hoover was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,080 times for 12 patients. In total Kara R Hoover billed 3,724 services in 57 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,080 | 12 | $0.10 | $109 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 451 | 202 | $9.53 | $4,298 |
| 99214 Office E&M - Established | Office | 439 | 186 | $69.77 | $31K |
| 99442 Telephone Services | Office | 255 | 162 | $52.96 | $14K |
| 80307 Drug Tests | Office | 240 | 124 | $58.43 | $14K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 230 | 118 | $233.83 | $54K |
| 99406 Behavioral Health Services | Office | 121 | 55 | $11.33 | $1,371 |
| 99443 Telephone Services | Office | 82 | 65 | $57.58 | $4,722 |
| 36415 Venipuncture Blood Collection | Office | 72 | 66 | $8.26 | $595 |
| 80053 Clinical Chemistry | Office | 69 | 63 | $10.23 | $706 |
| 82306 Clinical Chemistry | Office | 68 | 62 | $27.62 | $1,878 |
| 84439 Clinical Chemistry | Office | 67 | 61 | $8.41 | $563 |
| 85025 Blood Count | Office | 67 | 62 | $7.61 | $510 |
| 84443 Clinical Chemistry | Office | 65 | 60 | $16.06 | $1,044 |
| 81025 Clinical Chemistry | Office | 42 | 20 | $8.12 | $341 |
By year: 2022 $130K for 2,017 services; 2023 $160K for 2,521 services; 2024 $143K for 3,724 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 240 | 124 | $58.43 | $14K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 230 | 118 | $233.83 | $54K |
| 36415 Venipuncture Blood Collection | 72 | 66 | $8.26 | $595 |
| 80053 Clinical Chemistry | 69 | 63 | $10.23 | $706 |
| 82306 Clinical Chemistry | 68 | 62 | $27.62 | $1,878 |
| 84439 Clinical Chemistry | 67 | 61 | $8.41 | $563 |
| 85025 Blood Count | 67 | 62 | $7.61 | $510 |
| 84443 Clinical Chemistry | 65 | 60 | $16.06 | $1,044 |
| 81025 Clinical Chemistry | 42 | 20 | $8.12 | $341 |
| 84403 Clinical Chemistry | 24 | 19 | $24.30 | $583 |
Medicare prescription drug claims, 2024
In 2024, the drug Kara R Hoover prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 1,656 prescriptions and refills. In total Kara R Hoover wrote 9,530 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,656 | 1,656 | 396 | $75K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,181 | 1,181 | 305 | $40K |
| Gabapentin Generic | 948 | 1,072 | 258 | $13K |
| Oxycodone Hcl Generic | 774 | 774 | 200 | $23K |
| Pregabalin Generic | 538 | 580 | 169 | $13K |
| Tizanidine Hcl Generic | 455 | 523 | 132 | $4,104 |
| Cyclobenzaprine Hcl Generic | 444 | 500 | 150 | $4,409 |
| Morphine Sulfate Er Morphine Sulfate | 299 | 299 | 76 | $9,558 |
| Hydromorphone Hcl Generic | 174 | 174 | 77 | $4,301 |
| Tramadol Hcl Generic | 170 | 170 | 40 | $2,666 |
| Diclofenac Sodium Generic | 143 | 153 | 58 | $4,799 |
| Xtampza Er Oxycodone Myristate | 131 | 131 | 33 | $133K |
| Methocarbamol Generic | 112 | 129 | 46 | $1,993 |
| Morphine Sulfate Generic | 108 | 108 | 36 | $3,931 |
| Meloxicam Generic | 108 | 138 | 33 | $358 |
Brand drugs: 891 claims; generic drugs: 8,639 claims; opioid claims: 5,049.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kara R Hoover $803 ($803 in general payments such as food, travel and fees) from 8 companies. The largest payer was Pfizer Inc. with $183.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.